Early data on those looking outside traditional brain-dead donor pool Transmedics reporting good short-term clinical outcomes for DCD donor hearts assessed and preserved on the company’s OCS Heart System MEDPAGE TODAY By Nic Lou, Staff Writer | December 15, 2021 The limited practice of transplanting hearts from non-heart-beating donors has been associated with favorable outcomes and may be gaining traction, United Network for Organ Sharing (UNOS) registry data showed. Overall

HeartBrothers Foundation hosted its annual symposium on Dec. 2, featuring top doctors and experts who shared important new details in heart failure treatment and transplantation. HeartBrothers co-founder Pat Sullivan outlined goals and plans for the upcoming year, including a new virtual patient support group and heart failure billboard campaign. HeartBrothers members and supporters also spent time chatting, trading health updates and information about medications, new proced

Approval Enables Broader Utilization of Donor Hearts for Transplantation in the U.S. ANDOVER, Mass., Sept. 7, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its OCS Heart System for use with organs from donors a

Name:                    Glenn Rockwood Location:              Albany, NY Diagnosis:            Cardiomyopathy (40s) Transplanted:    February 8, 2017 (62) For nearly 20 years, Glenn lived his best life knowing eventually he would need a heart transplant. Diagnosed with cardiomyopathy and implanted with an internal cardiac device (ICD) defibrillator in his 40s, Glenn was equipped with a series of ICDs and eventually had to add a pacemaker after he developed a serious infectio